(R)-2-Amino-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid, 95.0%, 2g

Methyl 5-formylpyrazine-2-carboxylate, 98.0%, 10g

5-Methoxyisatin, 98.0%, 25g

2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid, 98.0%, 5mg

3-Bromo-1H-indol-5-amine hydrochloride, 250mg

(2E)-3-(4-chlorophenyl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

2-Chloro-6,7-dimethoxyquinazoline, 95.0%, 1g

1-(6-chloro-3-pyridinyl)-N,N-dimethylmethanamine, 95.0%, 250mg

Triethylsilanol>98.0%(GC)5mL

(3R)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid, 97%, 1g

METHYL 2,5-DICHLOROISONICOTINATE, 95.0%, 10g

2-(3-((2-Ethylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

1-((3-(trifluoromethyl)phenyl)sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 1g